AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT dated as of September, 20 2019 by and among APREA THERAPEUTICS, INC and the SHAREHOLDERS party hereto as set forth on Exhibit ARegistration Rights Agreement • September 25th, 2019 • Aprea Therapeutics, Inc. • Pharmaceutical preparations • New York
This Amended and Restated Registration Rights Agreement (this “Agreement”) is made and entered into as of September 20, 2019, (this “Agreement”) among Aprea Therapeutics, Inc. (the “Company”), and the shareholders party hereto as listed on Exhibit A, including any Permitted Transferees and New Investors (collectively, the “Shareholders”).
ContractCustoms Synthesis Agreement • September 25th, 2019 • Aprea Therapeutics, Inc. • Pharmaceutical preparations
*Certain information, identified by [***], has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
MASTER MANUFACTURING AND SUPPLY AGREEMENTMaster Manufacturing and Supply Agreement • September 25th, 2019 • Aprea Therapeutics, Inc. • Pharmaceutical preparations
This master manufacturing and supply agreement with its exhibits (“Agreement”) is made effective as of 19 September, 2019 (“Effective Date”) by and between:
